Bracco pushes for use of PET-based rubidium for heart scans

10/11/2009 | Diagnostic Imaging

Bracco Diagnostics is actively promoting the use of positron-based rubidium for heart scans as an alternative to the use of gamma-based technetium, which is currently in short supply. Bracco's CardioGen-82 generator of rubidium isotopes is the only available product for generator-based PET myocardial perfusion imaging approved by the FDA. The company said it can supply enough CardioGen-82 to address the demand for clinical cardiac scans during the ongoing shortage.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX